Brazil joins international research effort to cure hepatitis B
In the search for new treatments and even a cure for hepatitis B, two Brazilian public universities have joined forces with international institutions. The consortium is led by the Johns Hopkins University School of Medicine in the United States and comprises researchers from Brazil, India, Senegal, and Uganda . Brazil is represented by the Cassiano Antônio Moraes University Hospital of the…
Brazil has joined an international research effort to find a cure for hepatitis B, joining forces with Johns Hopkins University School of Medicine and institutions from India, Senegal, and Uganda. The consortium, led by Hucam-Ufes and USP, aims to study the cellular behavior of the virus in patients from various countries and their immune responses.
Tânia Reuter, a professor at Hucam-Ufes, emphasizes the goal of eliminating hepatitis B as a public health problem by 2030. Researchers will monitor 600 patients with hepatitis B, including those co-infected with HIV, for four and a half years. The study aims to identify genetic factors that may protect individuals from faster disease progression and predict treatment response.
Hepatitis B is a silent viral disease that can lead to cirrhosis, liver cancer, and death, affecting approximately 240 million people globally. In Brazil, there were 276,600 confirmed cases from 2000 to 2022. The WHO aims to eliminate HIV, viral hepatitis, and sexually transmitted infections as public health threats by 2030.
Written by urgent.news from Agencia Brasil's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
